Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

医学 吉西他滨 恶心 内科学 粘膜炎 危险系数 呕吐 胃肠病学 不利影响 临床终点 临床研究阶段 置信区间 化疗 外科 肿瘤科 随机对照试验
作者
Chigusa Morizane,Takuji Okusaka,Junki Mizusawa,Hiroshi Katayama,Makoto Ueno,Masafumi Ikeda,Masato Ozaka,Naohiro Okano,Kazuya Sugimori,Akira Fukutomi,Hiroki Hara,Nobumasa Mizuno,Hiroaki Yanagimoto,Keita Wada,Kazutoshi Tobimatsu,Kei Yane,Shoji Nakamori,Hiroyuki Yamaguchi,Akinori Asagi,Seigo Yukisawa,Yasushi Kojima,Ken Kawabe,Yasuyuki Kawamoto,Rie Sugimoto,Tomohisa Iwai,Kazuyoshi Nakamura,Hiroyoshi Miyakawa,Tatsuya Yamashita,A. Hosokawa,Tatsuya Ioka,Naoya Kato,Kazuhiko Shioji,Kyoko Shimizu,Toshio Nakagohri,Ken Kamata,Hiroshi Ishii,Junji Furuse
出处
期刊:Annals of Oncology [Elsevier BV]
卷期号:30 (12): 1950-1958 被引量:248
标识
DOI:10.1093/annonc/mdz402
摘要

BackgroundGemcitabine plus cisplatin (GC) is the standard treatment of advanced biliary tract cancer (BTC); however, it causes nausea, vomiting, and anorexia, and requires hydration. Gemcitabine plus S-1 (GS) reportedly has equal to, or better, efficacy and an acceptable toxicity profile. We aimed to confirm the non-inferiority of GS to GC for patients with advanced/recurrent BTC in terms of overall survival (OS).Patients and methodsWe undertook a phase III randomized trial in 33 institutions in Japan. Eligibility criteria included chemotherapy-naïve patients with recurrent or unresectable BTC, an Eastern Cooperative Oncology Group Performance Status of 0 − 1, and adequate organ function. The calculated sample size was 350 with a one-sided α of 5%, a power of 80%, and non-inferiority margin hazard ratio (HR) of 1.155. The primary end point was OS, while the secondary end points included progression-free survival (PFS), response rate (RR), adverse events (AEs), and clinically significant AEs defined as grade ≥2 fatigue, anorexia, nausea, vomiting, oral mucositis, or diarrhea.ResultsBetween May 2013 and March 2016, 354 patients were enrolled. GS was found to be non-inferior to GC [median OS: 13.4 months with GC and 15.1 months with GS, HR, 0.945; 90% confidence interval (CI), 0.78–1.15; P = 0.046 for non-inferiority]. The median PFS was 5.8 months with GC and 6.8 months with GS (HR 0.86; 95% CI 0.70–1.07). The RR was 32.4% with GC and 29.8% with GS. Both treatments were generally well-tolerated. Clinically significant AEs were observed in 35.1% of patients in the GC arm and 29.9% in the GS arm.ConclusionsGS, which does not require hydration, should be considered a new, convenient standard of care option for patients with advanced/recurrent BTC.Clinical Trial numberThis trial has been registered with the UMIN Clinical Trials Registry (http://www.umin.ac.jp/ctr/index.htm), number UMIN000010667.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彩色半烟完成签到,获得积分10
1秒前
量子星尘发布了新的文献求助10
5秒前
Ning完成签到,获得积分10
8秒前
图图完成签到,获得积分10
8秒前
勤奋的灯完成签到 ,获得积分10
8秒前
ludong_0完成签到,获得积分10
8秒前
Asumita完成签到,获得积分10
9秒前
双青豆完成签到 ,获得积分10
9秒前
11秒前
fxy完成签到 ,获得积分10
12秒前
合适的幻然完成签到,获得积分10
12秒前
沐雨汐完成签到,获得积分10
14秒前
16秒前
17秒前
jiayoujijin完成签到 ,获得积分10
17秒前
淡然思卉完成签到,获得积分10
18秒前
争当科研巨匠完成签到,获得积分10
18秒前
英姑应助认真的刺猬采纳,获得10
25秒前
好大一只小坏蛋完成签到,获得积分20
25秒前
站走跑完成签到 ,获得积分10
28秒前
步步高完成签到,获得积分10
30秒前
无私的雪瑶完成签到 ,获得积分10
30秒前
小杨完成签到,获得积分20
31秒前
小花完成签到 ,获得积分10
36秒前
宁夕完成签到 ,获得积分10
40秒前
西宁完成签到,获得积分10
40秒前
拼搏的羊青完成签到 ,获得积分10
41秒前
科目三应助asd113采纳,获得10
41秒前
deng203完成签到 ,获得积分20
43秒前
44秒前
时米米米完成签到,获得积分10
44秒前
浅浅完成签到,获得积分10
48秒前
量子星尘发布了新的文献求助10
53秒前
帅气的藏鸟完成签到,获得积分10
57秒前
加油完成签到 ,获得积分10
58秒前
健康的宛菡完成签到 ,获得积分10
59秒前
橙果果发布了新的文献求助20
59秒前
晚晚完成签到,获得积分10
1分钟前
1分钟前
听闻韬声依旧完成签到 ,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022